The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
The aim of the present study was to conduct a meta-analysis of the effectiveness of tofacitinib, a novel oral Janus kinase inhibitor, recently approved for the treatment of active rheumatoid arthritis in patients who have failed previous treatment with methotrexate (MTX) or other disease-modifying a...
Main Authors: | , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer London
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778229/ |